Positioning rituximab in the therapeutic strategies for SLE
Systemic lupus erythematosus (SLE) is one of the most challenging diseases to manage due to its high heterogeneity and unpredictable course. Rituximab is an off-label, widely administered treatment in severe, refractory SLE. Observational and real-world evidence studies have been highly heterogeneou...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-07-01
|
| Edice: | Frontiers in Lupus |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/flupu.2026.1877692/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|